The gene with the largest number of somatic variants identified was TP53, ranging from only 2.1% of patients with the variant in leukaemia to 46.6% of patients with the variant in colorectal cancer (Fig. 5, Part B). This evidence concerns the gene TP53 and colorectal cancer.